The aims of the Intellectual Property working group are to provide effective input at both national and international level on a range of important issues in intellectual property. It will also provide a forum for members to discuss issues that affect their companies.
The members are experts and specialist with a background from both industry and service providers.
Members
| Name |
Position |
Company |
| Annika Kilander (Chairman) |
Senior IP Councel |
GE Healthcare |
| Sara Gunnerås |
IP Project Manager |
Atlas Antibodies |
| Alexander Kovacs |
Global Market Manager |
Attana |
| Jörgen Linde |
Europan Patent Attorney |
Albihns |
| Hampus Rystedt |
European Patent Attorney |
Brann |
| Annika Unge |
European Patent Attorney |
Valea |
| Jan Alenfall |
CEO |
DermaGen |
| Richard Lewinson |
Advokat |
Bird & Bird |
| Karin Aase |
WG Coordinator |
SwedenBIO |
Key interests
- Strengthen IP competence and awareness among management teams
- Aid decision and policy makers by being a natural speaking partner for a fact-based dialogue
- Provide a forum for members on important issues affecting the companies
- Create insight of the potential and challenges of intellectual property rights as a tool for value creation
Notes from meetings
November 6, 2009
February 5, 2010
April 16, 2010
Contact: karin.aase@swedenbio.com